Myfortic (mycophenolic acid) - March 24, 2009

Audience: Renal, cardiac, and hepatic transplantation healthcare professionals

[UPDATE 03/24/2009] FDA and Novartis notified healthcare professionals of the introduction of a Myfortic Medication Guide to provide important safety information in language that patients can easily comprehend. By May 15, 2009, a copy of the Myfortic Medication Guide will be enclosed with every Myfortic bottle. Pharmacists are required to distribute a copy of the Medication Guide with every Myfortic prescription.

[Posted 02/12/2009] FDA and Roche Laboratories notified healthcare professionals of the introduction of a CellCept Medication Guide to provide important safety information in language that patients can easily comprehend. FDA regulations require a pharmacist to distribute a copy of the Medication Guide to every patient who fills a CellCept prescription from this point forward. FDA has also required the introduction of a Medication Guide for mycophenolic acid, marketed as Myfortic by Novartis.

[March 2009 - Dear Healthcare Professional Letter - Myfortic - Novartis]
[January 2009 - Dear Healthcare Provider Letter - CellCept - Roche]
[January 2009 - Dear Pharmacist Letter - CellCept - Roche]
[December 2008 - Medication Guide - CellCept - Roche]

Comments